A new topical

D M W Balak^{1

2}, E Hajdarbegovic³

Affiliations

Comment

D M W Balak et al. Br J Dermatol. 2022 Jan.

. 2022 Jan;186(1):5-6.

doi: 10.1111/bjd.20817. Epub 2021 Nov 2.

D M W Balak^{1

2}, E Hajdarbegovic³

No abstract available

Comment on

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial.
Saeki H, Baba N, Ito K, Yokota D, Tsubouchi H. Saeki H, et al. Br J Dermatol. 2022 Jan;186(1):40-49. doi: 10.1111/bjd.20655. Epub 2021 Nov 1. Br J Dermatol. 2022. PMID: 34289086 Free PMC article. Clinical Trial.

1. Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952; 19:101-2.
1. Smith JG Jr, Zawisza RJ, Blank H. Triamcinolone acetonide: a highly effective new topical steroid. AMA Arch Derm 1958; 78:643-5.
1. Williams DI, Wilkinson DS, Overton J et al. Betamethasone 17-valerate: a new topical corticosteroid. Lancet 1964; 1:1177-9.
1. Maibach HI. In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy. Dermatologica 1976; 152 (Suppl. 1):11-25.
1. Miller JA, Munro DD. Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 1980; 19:119-34.